Identification of cytoskeletal [14C]carboplatin-binding proteins reveals reduced expression and disorganization of actin and filamin in cisplatin-resistant cell lines

Molecular Pharmacology

Volumn 66, Issue 4, 2004, Pages 789-793

  Shen, Ding Wu ^a   Liang, Xing Jie ^a   Gawinowicz, Mary Ann ^b   Gottesman, Michael M ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ACTIN; BETA TUBULIN; CARBON 14; CARBOPLATIN; CISPLATIN; DRUG BINDING PROTEIN; DYNAMIN II; FILAMIN; FILAMIN 250; FILAMIN 90; GREEN FLUORESCENT PROTEIN; KERATIN; UNCLASSIFIED DRUG; ACTIN; ACTIN BINDING PROTEIN; ANTINEOPLASTIC AGENT; CARBON; CONTRACTILE PROTEIN; FILAMINS; TUBULIN;

ARTICLE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOSKELETON; DOWN REGULATION; DRUG RESISTANCE; ENDOCYTOSIS; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; MASS SPECTROMETRY; PHOTOAFFINITY LABELING; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; AMINO ACID SEQUENCE; CELL CULTURE; CHEMISTRY; DRUG EFFECT; GENE EXPRESSION; ISOLATION AND PURIFICATION; METABOLISM; MOLECULAR GENETICS; PHYSIOLOGY;

ACTINS; AMINO ACID SEQUENCE; ANTINEOPLASTIC AGENTS; CARBON RADIOISOTOPES; CARBOPLATIN; CISPLATIN; CONTRACTILE PROTEINS; CYTOSKELETON; DRUG RESISTANCE, NEOPLASM; DYNAMIN II; GENE EXPRESSION; HUMANS; KERATINS; MICROFILAMENT PROTEINS; MOLECULAR SEQUENCE DATA; TUBULIN; TUMOR CELLS, CULTURED;

EID: 4844221319     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.66.4.789     Document Type: Article

References (14)

1. Chauhan SS, Liang XL, Su AW, Shen DW, Hanover JA, and Gottesman MM (2003) Reduced endocytosis and altered lysosome function in CP-r cells. Br J Cancer 88:1327-1334.
2. Cornwell MM, Tsuruo T, Gottesman MM, and Pastan I (1987) ATP-binding properties of P-glycoprotein from multidrug-resistant KB cells. FASEB J 1:51-54.
3. Deverman BE, Cook BL, Manson SR, Niederhoff RA, Langer EM, Rosova I, Kulans LA, Fu X, Weinberg JS, Heinecke JW, et al. (2002) Bcl-xL deamidation is a critical switch in the regulation of the response to DNA damage. Cell 111:51-62.
4. Fojo T (2001) Cancer, DNA repair mechanisms and resistance to chemotherapy. J Natl Cancer Inst 93:1434-1436.
5. Gottesman MM, Fojo T, and Bates SE (2002) Multidrop resistance in cancer: role of ATP-dependent transporters. Nat Rev Cancer 2:48-58.
6. Liang XL, Shen DW, Garfleld S, and Gottesman MM (2003) Mislocalization of membrane proteins associated with multidrug resistance in CP-r cancer cell lines. Cancer Res 63:5909-5916.
7. Niedner H, Christen R, Lin X, Kondo A, and Howell SB (2001) Identification of genes that mediated sensitivity to cisplatin. Mol Pharmacol 60:1153-1160.
8. Pelkmans L, Punterner D, and Helenius A (2002) Local actin polymerization and dynamin recruitment in SV40-induced internalization of caveolae. Science (Wash DC) 296:535-539.
9. Qualmann B, Kessels MM, and Kelly RB (2000) Molecular links between endocytosis and the actin cytoskeleton. J Cell Biol 150:F111-F116.
10. Schafer DA (2002) Coupling actin dynamics and membrane dynamics during endocytosis. Curr Opin Cell Biol 14:76-81.
11. 14C]carboplatin in human CP-r cells results from reduced energy-dependent uptake. J Cell Physiol 183:108-116.
12. Shen DW, Pastan I, and Gottesman MM (1998) Cross-resistance to methotrexate and metals in human CP-r cell lines results from a pleiotropic defect in accumulation of these compounds associated with reduced plasma membrane binding proteins. Cancer Res 58:268-275.
13. Siddik ZH (2002) Biochemical and molecular mechanisms of cisplatin resistance. Cancer Treat Res 112:263-284.
14. Sorkin A (2000) The endocytosis machinery. J Cell Sci 113:4375-4376.